OTS167IV

DRUG3 trials

Sponsors

OncoTherapy Science, Inc.

Conditions

ALLAMLAdvanced CMLAdvanced MDSAdvanced MPNsHealthyMetastatic TumorsSolid Tumors

Phase 1

Phase 1 Study of OTS167 in Patients With Solid Tumors

CompletedNCT01910545

OncoTherapy Science, Inc.Metastatic Tumors, Solid Tumors

Start: 2013-08-23End: 2016-05-04Updated: 2017-06-01

Study to Evaluate Systemic Bioavailability of Oral OTS167 in Healthy Adult Subjects

CompletedNCT02768519

OncoTherapy Science, Inc.Healthy

Start: 2016-01-31End: 2016-02-29Updated: 2017-06-01

Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia

TerminatedNCT02795520

OncoTherapy Science, Inc.Advanced CML, Advanced MDS, Advanced MPNs +2

Start: 2016-04-30End: 2021-09-30Updated: 2021-11-24